GREVEN SIMONE
No ORCID on file
· 77 papers in corpus
· active 2011
Frequent coauthors
- WOLF SIEGMUND 66
- BRUDER SANDRA 66
- FREIBERG CHRISTOPH 66
- HARRENGA AXEL 66
- OTTO CHRISTIANE 66
- TRAUTWEIN MARK 66
- WILMEN ANDREAS 33
- EICKER ANDREA 33
- OTTO CHRISTIANE DR DR 11
- TRAUTWEIN MARK DR 11
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 002- H08, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 005- C04, as well as maturated forms thereof, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 002- H08, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 006- H08, as well as maturated forms thereof, and antigen-binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 006- H07, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 005- C04, as well as maturated forms thereof, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 006- H07, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 006- H08, as well as maturated forms thereof, and antigen-binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 005- C04, as well as maturated forms thereof, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 002- H06, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 002- H06, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 005- C04, as well as maturated forms thereof, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 005- C04, as well as maturated forms thereof, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or pre…
2011
The present invention is directed to the neutralizing prolactin receptor antibody 002- H06, and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indi…